Ayurvedic clinical trial on Paralysis

Randomized Clinical Study On Mahavatavidhvansa Rasa–Vaitarana Basti-Shirobasti in Combination on Pakshavadh with special reference to Cerebral Infarction - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058622

Enrollment

116

Registered

2023-10-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G811- Spastic hemiplegia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Pakshavadh mentioned in Ayurvedic texts. Patient having muscle power grade less than or equal to 3 Patients of Pakshavadh of duration not more than 5 years Patient willing and able to participate in the study Patients who have not participated in any research project in last 6 months Patients of Pakshavadh having controlled hypertension systolic BP up to 140 mm of Hg and diastolic up to 90 mm of Hg and diabetes mellitus (BSL fasting up to 130 mg/dl and Post Prandial up to 180 mg/dl

Exclusion criteria

Exclusion criteria: 1.Patients of cerebral infraction due to atrial fibrillation, embolic stroke, carotid occlusion, cerebellar stroke and hemorrhagic stroke will be excluded. 2.Patients having seizers, hydrocephalous, pulmonary embolism, dysphagia, M.I., cardiac arrhythmia and septicemia will be excluded. 3.Patients who have lost bowel and bladder control. 4.Comatose and unconscious patients. 5.Patients having age 70 years will be excluded. 6.Patients having intra cranial infection, encephalitis and meningitis etc. 7.Patient having trauma, cerebral tumour, cerebral abscess. 8.Patient with congenital heart diseases like POA, ASD, VSD and FOD. 9. Patients contraindicated for Abhyanga like skin diseases, infective disease etc. will be excluded. 10.Patients not fit for Basti. 11.Pregnant and lactating mothers. 12.Patients having acute progressive cerebral infarction.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Mahavatavidvansa Rasa Vaitarana Basti Shirobasti in combination on Barthel Index & NIH Stroke Scale on Pakshavadh with special reference to cerebral infarction. Timepoint: 17th Day & 31st Day	—

Secondary

Measure	Time frame
1.To compare the effect of Mahavatavidhvansa Rasa, Vaitarana Basti & Shirobasti in combination with effect of Ekangavir Rasa,Vaitarana Basti & Shirobasti on Barthel Index And NIH Stroke scale on Pakshavadh with special reference to cerebral infarction. 2. Any new theoretical or clinical outcome will be noted.Timepoint: 17th day & 31st day	—

Countries

India

Contacts

Public ContactAshish Thatere

A.P.Ms Ayurvedic Mahavidyalaya sion mumbai

anayapathrikar@gmail.com9870214595

Outcome results